We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Feb 2023 - 09 Feb 2023

CSF Immunoassays Aid Diagnosis of Early Alzheimer’s Disease

By LabMedica International staff writers
Posted on 21 Dec 2022
Print article
Image: The Cobas Е 801 Analyzer analytical unit is a high throughput immunochemistry module that performs a broad range of heterogeneous immunoassay tests (Photo courtesy of Dialogue Diagnostics LLC)
Image: The Cobas Е 801 Analyzer analytical unit is a high throughput immunochemistry module that performs a broad range of heterogeneous immunoassay tests (Photo courtesy of Dialogue Diagnostics LLC)

The pathological processes underlying Alzheimer’s disease (AD) begin many years before clinical presentation. Ongoing drug discovery efforts in AD focus on developing disease-modifying treatments aiming to delay onset or progression of dementia and must be initiated early in the disease process.

Cerebrospinal fluid (CSF) biomarkers beta-amyloid (1–42) (Aβ42), phosphorylated tau 181P (pTau181), and total tau (tTau) accurately identify early AD by detecting pathophysiological changes underlying the disease. CSF biomarkers should be measured robustly to aid diagnosis of AD; however, there are difficulties with CSF measurement, including pre-analytical and analytical factors.

Clinical Scientists at the Skåne University Hospital (Malmö, Sweden) and their colleagues assessed the analytical performance of second-generation (Gen II) Elecsys CSF immunoassays (Roche Diagnostics International Ltd, Penzberg, Germany), and adjusted existing cut-offs, to evaluate their potential utility in clinical routine. Samples were analyzed using Elecsys CSF Aβ42, pTau181, and tTau Gen II immunoassays on the Roche Diagnostics’ cobas e 801 analyzer. CSF samples (n>100) were analyzed using a single reagent lot with the three immunoassays on cobas e 801, e 402, e 601, and e 411 analyzers.

The investigators reported that the Gen II immunoassays demonstrated good analytical performance, including repeatability, intermediate precision, lot-to-lot agreement, and platform agreement. Aβ42 Gen I/Gen II immunoassay measurements were strongly correlated. Aβ42 Gen II immunoassay cut-offs were adjusted to 1,030 and 800 ng/L, and pTau181/Aβ42 ratio cut-offs to 0.023 and 0.029, for Gen II and I protocols, respectively. No observations were below the lower limit of the measuring range; above the upper limit, there were none from the AD cohort, and 2.6 and 6.8% from the mild cognitive impairment (MCI) and cognitively normal cohorts, respectively.

The authors concluded that the Elecsys CSF Gen II immunoassays demonstrated good analytical performance on extended cobas e platforms, including precision, lot-to-lot comparisons, and platform agreement, supporting their use in clinical routine to aid diagnosis of early AD. Elecsys CSF Gen II immunoassays provide additional benefits over the Gen I immunoassays, without compromising technical performance. Good technical performance of the immunoassays, plus reduced pre-analytical variability (a result of the new protocol), may provide a solution towards unified biomarker testing and timely diagnosis for patients with early AD. The study was published on October 24, 2022 in the journal Clinical Chemistry And Laboratory Medicine.

Related Links:
Skåne University Hospital
Roche Diagnostics International

Gold Supplier
Microplate Centrifuge & Reader
Lyra MP-Reader II
New
Portable Fixed Speed Centrifuge
Porta-Spin
New
HPV Control Panel
Human Papillomavirus (HPV) Control Panel
New
FOB Rapid Test Strip
FOB Rapid Test

Print article
MEDLAB - INFORMA

Channels

Molecular Diagnostics

view channel
Image: A novel research study moves the needle on predicting sudden cardiac arrest (Photo courtesy of Pexels)

Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes

Sudden cardiac arrest, or the sudden loss of heartbeat, is a life-threatening heart condition and often fatal. Despite providing an organized emergency medical response, less than 10% of individuals having... Read more

Immunology

view channel
Image: Histopathology of Langerhans cell histiocytosis: The variation in nuclear contours of these cells is evident in this lesion. Classic `kidney bean` nuclei of Langerhans cells with a central groove are present (Photo courtesy of John Lazarchick, MD)

Cooperativity Between Myeloid Lineages Promotes Langerhans Cell Histiocytosis Pathology

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia seen in children and adults who present with lesions composed of pathologic variants of myeloid cells that share certain phenotypic... Read more

Microbiology

view channel
Image: Medical illustration of Carbapenem-resistant Enterobacteriacea (Photo courtesy of CDC, Stephanie Rossow)

Breakthrough Test Enables Targeted Antibiotic Therapy for Various Enterobacter Species

Bacteria of the Enterobacter genus are considered to be the most dangerous bacteria linked to hospital infections across the world. Some of their representatives demonstrate high resistance to commonly-used... Read more

Technology

view channel
Image: Flexible copper sensor made cheaply from ordinary materials (Photo courtesy of University of São Paulo)

Low-Cost Portable Sensor Detects Heavy Metals in Sweat

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. However, they become toxic if they accumulate in the human body... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.